Twin Capital Management Inc. Decreases Stock Holdings in CME Group Inc. $CME

Twin Capital Management Inc. decreased its stake in shares of CME Group Inc. (NASDAQ:CME) by 87.4% during the third quarter, Holdings Channel reports. The firm owned 1,183 shares of the financial services provider’s stock after selling 8,240 shares during the quarter. Twin Capital Management Inc.’s holdings in CME Group were worth $320,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in CME. Amundi grew its stake in shares of CME Group by 24.0% during the 2nd quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock valued at $548,150,000 after acquiring an additional 385,225 shares during the period. Truist Financial Corp boosted its position in shares of CME Group by 8.9% in the third quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock worth $19,106,000 after purchasing an additional 5,773 shares during the period. Alley Investment Management Company LLC increased its stake in shares of CME Group by 86.0% in the third quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock worth $7,896,000 after purchasing an additional 13,512 shares in the last quarter. Elevate Capital Advisors LLC raised its position in shares of CME Group by 85.2% during the 3rd quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock valued at $2,302,000 after purchasing an additional 3,919 shares during the period. Finally, Victory Financial Group LLC raised its position in shares of CME Group by 310.2% during the 2nd quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock valued at $839,000 after purchasing an additional 2,302 shares during the period. Institutional investors own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on CME shares. Deutsche Bank Aktiengesellschaft increased their price target on CME Group from $312.00 to $316.00 and gave the stock a “buy” rating in a research note on Thursday. Weiss Ratings reiterated a “buy (b+)” rating on shares of CME Group in a research report on Monday, December 29th. Jefferies Financial Group lowered their price target on CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a report on Monday, January 12th. Piper Sandler increased their price objective on shares of CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Finally, The Goldman Sachs Group reduced their price objective on shares of CME Group from $265.00 to $264.00 and set a “sell” rating on the stock in a research report on Wednesday, January 14th. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $297.47.

CME Group Stock Performance

NASDAQ CME opened at $302.27 on Monday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $239.70 and a 1-year high of $302.79. The business has a 50 day simple moving average of $276.90 and a two-hundred day simple moving average of $273.00. The stock has a market capitalization of $109.00 billion, a PE ratio of 27.09, a P/E/G ratio of 3.29 and a beta of 0.27.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the company earned $2.52 EPS. The company’s quarterly revenue was up 8.1% compared to the same quarter last year. On average, research analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Q4 earnings beat and commentary reinforced the firm’s resilient fee-based franchise — investors reacted to better-than-expected quarterly results and the company hitting a new one-year high after the report. Earnings Call Transcript
• Positive Sentiment: Deutsche Bank raised its price target to $316 and maintained a buy rating, giving fresh analyst support that can help momentum. Deutsche Bank PT Raise
• Positive Sentiment: Morgan Stanley reiterated a Buy rating, highlighting CME’s defensive, fee-based franchise and structural growth drivers. Morgan Stanley Note
• Neutral Sentiment: RBC nudged its target to $302 (sector perform) — a small technical change that largely preserves prior sentiment. RBC PT Adjustment
• Positive Sentiment: Management confirmed the firm is exploring a CME-issued digital token and tokenized cash pilots (including work with Google), a strategic move that could expand 24/7 crypto/product offerings and new non-trading revenue streams. CME Token Exploration
• Negative Sentiment: CME raised initial and maintenance margins for gold and silver futures (e.g., gold margins to 9% from 8%, silver to 18% from 15%) to manage sharp volatility — measures that can damp trading volume and futures activity in the near term. Margin Hikes
• Negative Sentiment: Pelican Bay Capital reported selling CME in Q4, signaling at least some institutional trimming that could weigh on sentiment if others follow. Institutional Selling
• Negative Sentiment: JPMorgan still carries an underweight rating despite updating its target — a reminder there are pockets of skepticism about valuation and upside. JPMorgan Note

Insiders Place Their Bets

In other CME Group news, Director William R. Shepard purchased 251 shares of the stock in a transaction that occurred on Tuesday, December 30th. The stock was purchased at an average price of $278.37 per share, with a total value of $69,870.87. Following the acquisition, the director owned 258,710 shares in the company, valued at approximately $72,017,102.70. The trade was a 0.10% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Terrence A. Duffy sold 25,000 shares of CME Group stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $269.55, for a total value of $6,738,750.00. Following the completion of the transaction, the chief executive officer owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. This represents a 27.53% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.